Posted by ABMN Staff on Mar 30th, 2024
Akebia Therapeutics, Inc. (NASDAQ:AKBA – Get Free Report) was the recipient of a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 10,130,000 shares, an increase...
More of this article »